Evidence map›Paper›PMID 35768423›Full record

ArticleNPJ Parkinson's disease2022

STN-DBS does not increase the risk of sialorrhea in patients with advanced Parkinson's disease.

Francesco Bove, Danilo Genovese, Martina Petracca, Tommaso Tufo, Danila Pisani, Maria Rita Lo Monaco, Anna Rita Bentivoglio, Paolo Calabresi, Carla Piano

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in NPJ Parkinson's disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Francesco BoveNeurology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.ORCID http://orcid.org/0000-0002-2959-6659
Danilo GenoveseNeurology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Martina PetraccaNeurology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. martina.petracca@policlinicogemelli.it.ORCID http://orcid.org/0000-0001-8033-3785
Tommaso TufoNeurosurgery Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Danila PisaniDepartment of Neuroscience, Università Cattolica del Sacro Cuore, Rome, Italy.
Maria Rita Lo MonacoMedicine of Ageing, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Anna Rita BentivoglioNeurology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Paolo CalabresiNeurology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Carla PianoNeurology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.ORCID http://orcid.org/0000-0003-0265-7666
Università Cattolica del Sacro Cuore · ITAgostino Gemelli University Polyclinic · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aims of this study were to assess the incidence rate and risk factors for sialorrhea in the long-term follow-up in a cohort of 132 patients with advanced Parkinson's disease [88 with deep brain stimulation (DBS) and 44 on medical treatment]. The incidence rate of sialorrhea did not differ between the two groups; male sex, Hoehn and Yahr stage and dysphagia resulted risk factors for sialorrhea. These findings indicate that DBS does not increase the risk of developing sialorrhea.

Identifiers

PMID35768423
PMCPMC9243012
OpenAlexW4283764382

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.